Literature DB >> 25907755

New criteria for Alzheimer's disease: which, when and why?

Jonathan M Schott1, Ronald C Petersen2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25907755      PMCID: PMC5963410          DOI: 10.1093/brain/awv055

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  10 in total

1.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 2.  Clinical amyloid imaging in Alzheimer's disease.

Authors:  Karl Herholz; Klaus Ebmeier
Journal:  Lancet Neurol       Date:  2011-07       Impact factor: 44.182

Review 3.  Clinical practice. Mild cognitive impairment.

Authors:  Ronald C Petersen
Journal:  N Engl J Med       Date:  2011-06-09       Impact factor: 91.245

Review 4.  Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges.

Authors:  Jonathan W Bartlett; Chris Frost; Niklas Mattsson; Tobias Skillbäck; Kaj Blennow; Henrik Zetterberg; Jonathan M Schott
Journal:  Biomark Med       Date:  2012-08       Impact factor: 2.851

5.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Harald Hampel; José Luis Molinuevo; Kaj Blennow; Steven T DeKosky; Serge Gauthier; Dennis Selkoe; Randall Bateman; Stefano Cappa; Sebastian Crutch; Sebastiaan Engelborghs; Giovanni B Frisoni; Nick C Fox; Douglas Galasko; Marie-Odile Habert; Gregory A Jicha; Agneta Nordberg; Florence Pasquier; Gil Rabinovici; Philippe Robert; Christopher Rowe; Stephen Salloway; Marie Sarazin; Stéphane Epelbaum; Leonardo C de Souza; Bruno Vellas; Pieter J Visser; Lon Schneider; Yaakov Stern; Philip Scheltens; Jeffrey L Cummings
Journal:  Lancet Neurol       Date:  2014-06       Impact factor: 44.182

6.  Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.

Authors:  Stephanie J B Vos; Frans Verhey; Lutz Frölich; Johannes Kornhuber; Jens Wiltfang; Wolfgang Maier; Oliver Peters; Eckart Rüther; Flavio Nobili; Silvia Morbelli; Giovanni B Frisoni; Alexander Drzezga; Mira Didic; Bart N M van Berckel; Andrew Simmons; Hilkka Soininen; Iwona Kłoszewska; Patrizia Mecocci; Magda Tsolaki; Bruno Vellas; Simon Lovestone; Cristina Muscio; Sanna-Kaisa Herukka; Eric Salmon; Christine Bastin; Anders Wallin; Arto Nordlund; Alexandre de Mendonça; Dina Silva; Isabel Santana; Raquel Lemos; Sebastiaan Engelborghs; Stefan Van der Mussele; Yvonne Freund-Levi; Åsa K Wallin; Harald Hampel; Wiesje van der Flier; Philip Scheltens; Pieter Jelle Visser
Journal:  Brain       Date:  2015-02-17       Impact factor: 13.501

Review 7.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Authors:  Kaj Blennow; Harald Hampel; Michael Weiner; Henrik Zetterberg
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

Review 8.  Tau imaging: early progress and future directions.

Authors:  Victor L Villemagne; Michelle T Fodero-Tavoletti; Colin L Masters; Christopher C Rowe
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

9.  Mild cognitive impairment due to Alzheimer disease in the community.

Authors:  Ronald C Petersen; Paul Aisen; Bradley F Boeve; Yonas E Geda; Robert J Ivnik; David S Knopman; Michelle Mielke; Vernon S Pankratz; Rosebud Roberts; Walter A Rocca; Stephen Weigand; Michael Weiner; Heather Wiste; Clifford R Jack
Journal:  Ann Neurol       Date:  2013-08       Impact factor: 10.422

Review 10.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Steven T Dekosky; Pascale Barberger-Gateau; Jeffrey Cummings; André Delacourte; Douglas Galasko; Serge Gauthier; Gregory Jicha; Kenichi Meguro; John O'brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2007-08       Impact factor: 44.182

  10 in total
  4 in total

Review 1.  A short perspective on the long road to effective treatments for Alzheimer's disease.

Authors:  David S Reynolds
Journal:  Br J Pharmacol       Date:  2019-03-01       Impact factor: 8.739

2.  Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.

Authors:  Jennifer Andreotti; Thomas Dierks; Lars-Olof Wahlund; Matthias Grieder
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Computational integration of nanoscale physical biomarkers and cognitive assessments for Alzheimer's disease diagnosis and prognosis.

Authors:  Tao Yue; Xinghua Jia; Jennifer Petrosino; Leming Sun; Zhen Fan; Jesse Fine; Rebecca Davis; Scott Galster; Jeff Kuret; Douglas W Scharre; Mingjun Zhang
Journal:  Sci Adv       Date:  2017-07-28       Impact factor: 14.136

4.  Sirt-1 Regulates Physiological Process and Exerts Protective Effects against Oxidative Stress.

Authors:  Lei Liu; Guangyuan Xia; Peifan Li; Yiming Wang; Qian Zhao
Journal:  Biomed Res Int       Date:  2021-03-23       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.